Lewy Body Disease Clinical Trials in Scottsdale, Arizona
2 recruitingScottsdale, Arizona
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive DysfunctionLewy Body DiseaseAmyloid+1 more
Eli Lilly and Company350 enrolled72 locationsNCT07589595
Recruiting
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
HealthyAlzheimer DiseaseLewy Body Disease
Mayo Clinic90 enrolled1 locationNCT06057909